IPO supply is back—but earnings still have to earn liquidity

The fourth quarter’s public-markets story is not simply that listings are returning. It is that new supply, lockup releases, secondary liquidity and company-level execution are arriving at the same time—and the market is becoming more selective about what it will absorb.

The working hypothesis for this desk is constructive: earnings growth and resilient demand can support DDOG, SNOW, CRWV, AN, RH, WSM, ETH and LZB over the next year. The market-structure test is whether those fundamentals can keep attracting buyers when fresh shares, higher funding costs and thinner pockets of liquidity compete for the same capital.

A reopening, but not a broad risk-on cycle

The latest IPO evidence supports a measured interpretation. Renaissance Capital’s third-quarter review counted 30 U.S. listings and $32.8 billion of proceeds, while noting that concerns about AI spending, rising rates and postponements weighed on the quarter.^[1] Nasdaq’s October commentary likewise described the IPO pulse as softer in September, not broken, against a backdrop of higher yields and macro uncertainty.^[1]

That distinction matters. A headline proceeds number can be dominated by a small number of large transactions; it does not prove that the market is providing uniformly deep liquidity to every new issue. The more useful signal is the breadth of demand: how many deals price, how many are postponed, how secondary shares trade after the first lockup window, and whether daily volume remains available when early enthusiasm fades.

The current calendar illustrates the point. Public IPO calendars show several pricings in the week of October 18–24, but the presence of deals is not the same as a durable issuance window.^[2] For issuers, price discovery is only the first gate. After listing, a stock must develop a functioning two-sided market while employees, venture investors and other early holders gradually gain the ability to sell.

Why liquidity is the binding constraint

Liquidity is the mechanism that converts a credible business trajectory into investable public-market capacity. When liquidity is abundant, a company can raise equity, insiders can diversify and institutions can adjust exposure without moving the price excessively. When liquidity is scarce, even a good operating update can compete with supply from a follow-on, a block or a lockup release.

The market-plumbing backdrop is also changing. The SEC has proposed amendments to Regulation NMS covering trade-through, locked and crossed markets.^[3] Exchange filings and rule changes continue to focus on initial-listing liquidity requirements and trading controls.^[3]

The company evidence is mixed—and that is useful

Snowflake reported fiscal-third-quarter product revenue of $1.16 billion, up 29% year over year, with 125% net revenue retention and $7.88 billion of remaining performance obligations, up 37%.^[4] Datadog’s investor materials reported first-quarter 2026 revenue growth of 32% to $1.006 billion and approximately 4,550 customers with at least $100,000 of ARR.^[5] CoreWeave’s second-quarter release highlighted record revenue and backlog, with AI cloud demand as a central driver.^[4]

Those facts support the bullish case, but they do not settle it. Software growth must translate into durable workloads and cash generation. AI infrastructure demand must be tested against capital intensity, customer concentration, financing costs and the possibility that supply catches up with demand.

AN, RH, WSM, ETH and LZB provide a different test, with greater sensitivity to household demand, housing-linked spending, product cycles and promotional conditions. Their earnings reactions can broaden the read beyond AI: if buyers remain selective despite stable operating evidence, valuation, rates or liquidity—not just demand—may be the binding constraint.

The latest regular-session snapshot was differentiated: DDOG rose 4.62% and SNOW 3.65% on October 23, while WSM fell 3.19%, CRWV fell 2.46% and RH fell 1.94%.^[6] That is one day, not a verdict, but it is consistent with a market rewarding selected growth evidence rather than lifting every name together.

Earnings are the next price-discovery event

DDOG is scheduled for November 4, 2026, before the open, although the calendar labels that date estimated and lists November 5 as an alternate. AN is scheduled for October 30 before the open; RH for December 10 after the close; WSM for November 18 before the open; LZB for November 17 after the close; and SNOW for December 2 after the close. The calendar has no confirmed date for ETH, while CRWV is unsupported in that schedule.^[7]

The questions are straightforward: Are software customers expanding workloads? Does AI backlog convert into revenue and cash without disproportionate financing burden? Are consumer businesses seeing durable full-price demand? When new supply arrives, does trading depth absorb it without persistent dislocation? Are buybacks large enough to offset issuance?

What to watch next

1. The IPO calendar after the next macro shock: whether postponed or newly filed deals return without unusually large concessions.
2. Lockup and secondary supply: dates and sizes of unlocks, follow-ons and blocks; sizeable unlocks can cluster soon after listing.^[8]
3. Depth, not just volume: spreads, intraday reversals and the ability to transact through volatility.
4. Earnings quality: DDOG and SNOW test recurring enterprise demand; CRWV tests AI-capacity economics; AN, RH, WSM, ETH and LZB test the consumer channel.
5. Market-structure implementation: SEC and exchange proposals affecting trade-through rules, listing liquidity and trading pauses.^[3]

The balanced conclusion is that the IPO window appears open, but selective. The bullish hypothesis becomes more credible if operating growth remains broad, financing needs manageable and new supply clears without persistent dislocation. The skeptical case gains ground if demand is concentrated in a few issuers while lockups, secondaries and higher rates expose shallow liquidity underneath the headline reopening.

This is market research, not investment advice.